Company and Case Information

Home

Index of Filings

News and Press Releases

Filings

Decisions

Settlements

Litigation Activity Indices

Top Ten List

Annual/Quarterly Updates

Clearinghouse Research

Articles & Papers

Search

Related Sites

About Us

Local Rules

Sponsors


Register


_______________
Copyright (c) 2001
Stanford Law School


DOV Pharmaceutical, Inc.
Conclusion: In April 2003, the Company received a court order approving the proposed settlement with plaintiffs in class action shareholder lawsuits filed following its initial public offering. Pursuant to the settlement agreement, the Company paid to the class members (inclusive of their attorney fees and costs) $250,000 and issued them 500,000 six-year warrants to purchase its common stock at an exercise price of $10.00 per share. The Company also reached an agreement with the primary carrier of its directors' and officers' insurance policy such that the carrier paid to the Company $1.6 million in settlement for the shareholders' class action lawsuit.

The original action charged DOV and certain of its officers and directors, and the lead underwriters of DOV's IPO, CIBC World Markets and Lehman Brothers, with violations of Sections 11 and 12 of the Securities Act of 1933. DOV issued five million shares in its IPO on April 25, 2002 at $13 a share, but failed to timely inform the Class of a revision of its 1999 financial results to properly include a Joint Venture in Bermuda with Elan Corporation. The class of purchasers of the shares in the IPO or in the aftermarket were not promptly made aware of the restatement, and as a result, suffered losses on the first day of trading or thereafter, when the shares of DOV fell from $13 to $8.70 per share.

INDUSTRY CLASSIFICATION:
SIC Code: 2834
Sector: Healthcare
Industry: Biotechnology & Drugs


COMPANY/ISSUER NAME: DOV Pharmaceutical, Inc.
COMPANY/ISSUER TICKER: DOVP
COMPANY WEBSITE: www.dovpharm.com/

FIRST IDENTIFIED COMPLAINT IN THE DATABASE
Hillhouse Capital Fund, L.P., and Turnberry Asset Management, et al. v. DOV Pharmaceutical, Inc., et al.
 COURT: S.D. New York  DOCKET NUMBER: 02-CV-3271
 JUDGE NAME: Hon. Robert W. Sweet
 DATE FILED: 04/29/2002  SOURCE: Business Wires
 CLASS PERIOD START: 04/25/2002  CLASS PERIOD END: 04/25/2002
 TYPE OF COMPLAINT: Unamended/Unconsolidated
 PLAINTIFF FIRMS IN THIS OR SIMILAR CASE:
  • Abbey Gardy, LLP
      212 East 39th Street, New York, NY, 10016
       (voice) 212.889.3700, (fax) , info@abbeygardy.com
  • Brian Felgoise
      230 South Broad Street, Suite 404 , Philadelphia, PA, 19102
       (voice) 215.735.6810, (fax) 215/735.5185.,
  • Cauley Geller Bowman Coates & Rudman LLP (Little Rock, AR)
      P.O. Box 25438, Little Rock, AR, 72221-5438
       (voice) 501.312.8500, (fax) 501.312.8505,
  • Cohen Milstein Hausfeld & Toll PLLC (Seattle WA)
      701 Fifth Avenue, Suite 6860, Seattle, WA, 98014
       (voice) 206.521.0080, (fax) 206.521.0166, lawinfo@cmht.com
  • Faruqi & Faruqi LLP
      320 East 39th Street, New York, NY, 10016
       (voice) 212.983.9330, (fax) 212.983.9331, Nfaruqi@faruqilaw.com
  • Kirby McInerney & Squire LLP
      830 Third Avenue 10th Floor, New York Ave, NY, 10022
       (voice) 212.317.2300, (fax) ,
  • Law Offices of Charles J. Piven, P.A.
      World Trade Center-Baltimore,401 East Pratt Suite 2525, Baltimore, MD, 21202
       (voice) 410.332.0030, (fax) , pivenlaw@erols.com
  • Schoengold & Sporn PC
      233 Broadway 39Th Floor, New York, NY, 10279
       (voice) 212.964.0046, (fax) ,
  • Slotnick Shapiro & Crocker, LLP
      100 Park Avenue - 35th Floor, New York, NY, 10017
       (voice) 212.687.5000, (fax) 212.687.3080,
  • Weiss & Yourman (New York, NY)
      The French Building, 551 Fifth Ave., Suite 1600, New York, NY, 10126
       (voice) 212.682.3025, (fax) 212.682.3010, info@wyca.com
  • Wolf Haldenstein Adler Freeman & Herz LLP
      270 Madison Avenue, New York, NY, 10016
       (voice) 212.545.4600, (fax) 212.686.0114, newyork@whafh.com
    _____________________________________________
     TOTAL NUMBER OF PLAINTIFF FIRMS:  11

  •  DOCUMENTS FOR THE FIRST IDENTIFIED COMPLAINT
    Class Action Complaint For Violations Of The Federal Securities Laws
    Type: Complaint Date on the document: 04/30/2002
    Notice Of Pendency Of Class Actions, Proposed Settlement And Hearing Thereon
    Type: Notice Date on the document: 02/14/2003
    U.S. District Court Civil Docket
    Type: Docket Date on the document: 10/31/2003

     OTHER DOCUMENTS
    Class Action Complaint For Violations Of The Federal Securities Laws
    Case Name and/or Number: Cooper
    Type: Complaint Date on the document: 05/07/2002
    Class Action Complaint For Violations Of The Federal Securities Laws
    Case Name and/or Number: Leffler
    Type: Complaint Date on the document: 05/29/2002

    WARNING AND DISCLAIMER OF LIABILITY:
    The information included on this Web site, whether provided by personnel employed by Stanford Law School or by third parties, is provided for research and teaching purposes only. Neither Stanford University, Stanford Law School, nor any of their employees, agents, contractors, or affiliates warrant the accuracy or completeness of the information or analyses displayed herein, and we caution all readers that inclusion of any information on this site does not constitute an endorsement of the truthfulness or accuracy of that information. In particular, this Web site contains complaints and other documents filed in federal and state courts, which make allegations that may or may not be accurate. No reader should, on the basis of information contained in or referenced by this Web site, assume that any of these allegations are truthful.
    Go to Search  page | Go to Case Index  page | Back to Top